Medical Director, Immunology Clinical Development

BioSpace; Boston (MA); Hybrid; USD 266,000 - 340,000; Full time

Benefits offered by this job

Hybrid schedule

Competitive benefits

Bonus/equity incentives

Job summary

Beeline Medicines is seeking a Medical Director, Clinical Development to provide medical leadership across immunology-focused clinical programs. You will shape study design, safety monitoring, and data interpretation, collaborating with cross-functional teams to advance assets through early to late-stage trials.

The role requires an MD/DO (MD/PhD preferred) with 5+ years in pharma/biotech, experience in lupus or autoimmune diseases, and proven regulatory writing and submission involvement.

Qualifications

• Minimum 5 years of combined clinical and pharma/biotech industry experience.
• Direct experience treating or managing lupus (SLE/CLE) and/or systemic sclerosis programs preferred.
• Deep scientific expertise in autoimmune disease and immunology.
• Experience in phase 1-3 clinical studies and regulatory documents.

Responsibilities

• Provide medical oversight for licensed clinical trials including design and monitoring.
• Contribute to clinical development strategy and program plans.
• Lead trial design decisions on endpoints, eligibility, dose rationale and biomarker strategy.
• Monitor patient safety and data integrity across studies.
• Support regulatory submissions and interactions with health authorities.

Skills

Cross-functional collaboration

Scientific communication

Leadership

Regulatory understanding

Education

MD or DO

MD/PhD

Board certification in rheumatology/immunology

Job description

Beeline Medicines is seeking a Medical Director, Clinical Development to provide medical leadership across immunology-focused clinical programs. You will shape study design, safety monitoring, and data interpretation, collaborating with cross-functional teams to advance assets through early to late-stage trials.

The role requires an MD/DO (MD/PhD preferred) with 5+ years in pharma/biotech, experience in lupus or autoimmune diseases, and proven regulatory writing and submission involvement.